Trexquant Investment LP Buys 657 Shares of agilon health, inc. (NYSE:AGL)

Trexquant Investment LP raised its stake in shares of agilon health, inc. (NYSE:AGL – Get Rating) by 1.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,913 shares of the company’s stock after buying an additional 657 shares during the period. Trexquant Investment LP’s holdings in agilon health were worth $1,263,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. UBS Asset Management Americas Inc. increased its stake in shares of agilon health by 13.5% in the third quarter. UBS Asset Management Americas Inc. now owns 301,464 shares of the company’s stock worth $7,060,000 after purchasing an additional 35,905 shares during the period. Vanguard Group Inc. increased its stake in shares of agilon health by 14.7% in the third quarter. Vanguard Group Inc. now owns 18,770,560 shares of the company’s stock worth $439,605,000 after purchasing an additional 2,407,116 shares during the period. Pearl River Capital LLC bought a new position in shares of agilon health in the third quarter worth about $242,000. Portolan Capital Management LLC bought a new position in shares of agilon health in the third quarter worth about $4,351,000. Finally, Quadrature Capital Ltd bought a new position in shares of agilon health in the third quarter worth about $624,000.

Wall Street Analysts Forecast Growth

AGL has been the topic of a number of recent research reports. Guggenheim lifted their target price on agilon health from $21.00 to $30.00 and gave the stock a “buy” rating in a research report on Monday, March 6th. Stifel Nicolaus initiated coverage on agilon health in a research report on Thursday, December 8th. They set a “buy” rating and a $23.00 target price on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on agilon health from $26.00 to $28.00 in a research report on Friday, March 3rd. The Goldman Sachs Group decreased their target price on agilon health from $38.00 to $34.00 and set a “buy” rating on the stock in a research report on Tuesday, November 15th. Finally, Wells Fargo & Company decreased their target price on agilon health from $28.00 to $22.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 15th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $28.63.

agilon health Stock Up 1.0 %

NYSE AGL opened at $23.06 on Tuesday. The company has a current ratio of 2.71, a quick ratio of 2.71 and a debt-to-equity ratio of 0.04. The stock’s 50 day moving average is $21.24 and its two-hundred day moving average is $20.30. The company has a market capitalization of $9.53 billion, a price-to-earnings ratio of -88.69 and a beta of 1.09. agilon health, inc. has a 1-year low of $14.82 and a 1-year high of $28.36.

Insider Buying and Selling at agilon health

In other agilon health news, insider Benjamin Shaker sold 28,555 shares of agilon health stock in a transaction that occurred on Wednesday, February 15th. The stock was sold at an average price of $23.37, for a total transaction of $667,330.35. Following the sale, the insider now directly owns 25,625 shares of the company’s stock, valued at $598,856.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Benjamin Shaker sold 28,555 shares of the business’s stock in a transaction that occurred on Wednesday, February 15th. The stock was sold at an average price of $23.37, for a total value of $667,330.35. Following the transaction, the insider now directly owns 25,625 shares of the company’s stock, valued at approximately $598,856.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Benjamin Kornitzer sold 2,698 shares of the business’s stock in a transaction that occurred on Thursday, January 5th. The stock was sold at an average price of $15.51, for a total value of $41,845.98. Following the completion of the transaction, the insider now directly owns 10,426 shares in the company, valued at $161,707.26. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 70,864 shares of company stock valued at $1,515,177. 3.30% of the stock is currently owned by corporate insiders.

About agilon health

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.